Filter By Category
Archives
BUPARLISIB
Generic Name: BUPARLISIB
ABSTRACT -
Buparlisib is an orally active pan-class I phosphoinositide 3-kinase inhibitor studied in oncology. Its clinical use depends on trial or regulatory status and requires close monitoring for metabolic, hepatic, dermatologic, and neuropsychiatric adverse effects.
DOSAGE -
Buparlisib should be taken or administered only as prescribed by a qualified healthcare professional.
- If the product is investigational or not locally approved, there is no standard public dosage and use should be limited to authorized clinical protocols.
- Dose selection depends on indication, formulation, route, patient factors, and safety monitoring requirements.
- Patients should not start, stop, or change therapy without medical advice.
SIDE EFFECTS-
Common or possible side effects may include:
- Nausea
- Vomiting
- Fatigue
- Reduced appetite
- Low blood-cell counts
- Liver enzyme changes
- Rash
- Metabolic or organ-specific toxicity depending on dose
Serious adverse effects depend on dose, route, indication, comorbidities, and concomitant medicines.
ALLERGIC REACTIONS -
Buparlisib may cause allergic or hypersensitivity reactions. Risk may be higher in patients with previous reactions to related products or excipients.
Symptoms may include:
- Fever
- Skin rash
- Itching
- Hives
- Swelling of face, lips, tongue, or throat
- Wheezing or shortness of breath
- Severe dizziness
- Low blood pressure
- Anaphylaxis in severe cases
Important: Stop treatment and seek urgent medical help if a serious allergic reaction is suspected.
DRUG INTERACTIONS-
Buparlisib may interact with certain medicines or substances. Caution is needed with:
- Strong CYP3A inhibitors or inducers
- Other anticancer medicines
- Medicines affecting blood glucose
- Medicines affecting mood or cognition
- Hepatotoxic medicines
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, and supplements they are using.
PREAUTONS–
- Use only under medical supervision.
- Review allergy history before use.
- Inform healthcare providers about all medicines and supplements.
- Use caution in pregnancy, breastfeeding, pediatric, geriatric, renal, or hepatic impairment unless specifically evaluated.
WARNINGS –
- Serious allergic reactions may occur.
- Overdose or incorrect use may cause severe toxicity.
- Use caution with medicines that have overlapping effects or toxicity.
- In case of severe side effects, overdose, difficulty breathing, or allergic reaction, seek emergency medical care immediately.



. Developed by